Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Autonomous & Electric Vehicles (DRIV) vs HCA Health Inc (HCA) Price & Performance

Global X Autonomous & Electric VehiclesTrade
HCA Health IncTrade

Price performance (Past 24H)

Key statistics

Global X Autonomous & Electric Vehicles vs HCA Health Inc — how do they compare? Global X Autonomous & Electric Vehicles trades at $32.44 (market cap $356.37M), while HCA Health Inc trades at $443.69 (market cap $96.35B). The key difference: HCA Health Inc is far larger — about 270.4× Global X Autonomous & Electric Vehicles's market cap, and HCA Health Inc pays a 0.7% dividend while Global X Autonomous & Electric Vehicles pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Autonomous & Electric Vehicles for 40 Days and HCA Health Inc for 76 Days on average.

DRIVHCA
Market Cap
$356.37M$96.35B
Volume
22,3971,079,453
Sector
Sector/ThematicHealth
52-Week High
$42.53$545.13
52-Week Low
$27.58$361.32
Typical Hold Time
40 Days76 Days
Enterprise Value
—$146.88B
Dividend Yield
—0.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Autonomous & Electric Vehicles

DRIV trades at $33.37, down 1.68% today amid mixed technical signals. The overall technical outlook is bullish with neutral oscillators, while key support sits at $33. Recent news highlights automotive sector focus on hybrid and electric vehicles, though company-specific financial ratios are currently unavailable for analysis.

The stock shows technical resilience near support levels with bullish momentum indicators. Investment appeal hinges on forthcoming financial disclosures and sector trends favoring EV/hybrid adoption. Key risks include sector competition and reliance on broader automotive market performance without current fundamental data.

HCA Health Inc

HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.

The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DRIV
0% Buy100% Sell
Avg holding period · 40 Days
HCA
100% Buy0% Sell
Avg holding period · 76 Days

About Global X Autonomous & Electric Vehicles

DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.

Read more on DRIV →

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →